World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 25 April 2016
Main ID:  NCT02736682
Date of registration: 07/04/2016
Prospective Registration: No
Primary sponsor: Makerere University
Public title: Single Dose Ceftriaxone and Metronidazole Versus Multiple Doses for Antibiotic Prophylaxis at Elective Cesarean Section. SDvMD
Scientific title: Single Dose Ceftriaxone and Metronidazole Versus Multiple Doses for Antibiotic Prophylaxis at Elective Cesarean Section in Mulago Hospital. A Randomized Clinical Trial.
Date of first enrolment: September 2015
Target sample size: 174
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02736682
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 4
Countries of recruitment
Uganda
Contacts
Name:     Imelda Namagembe, MD, MMeD, MPH
Address: 
Telephone:
Email:
Affiliation:  Mulago NAtional Referral Hospital
Name:     Mugisa Alex Gideon, MBChB.
Address: 
Telephone:
Email:
Affiliation:  Makerere University Collage of Health Sciences, Department of Obstetrics and Gynecology
Name:     Paul Kiondo, MD, MMeD,PhD
Address: 
Telephone:
Email:
Affiliation:  Makerere University Collage of Health Sciences, Department of Obstetrics and Gynecology
Key inclusion & exclusion criteria

Inclusion Criteria:

- Antenatal mothers who have an indication for elective cesarean section in New Mulago
hospital.

Exclusion Criteria:

- Mothers who have a history of allergy to any of the drugs in the study, Mother with
visible infection at any site or elevated body temperature before going to theatre,
Those with rapture of membranes, Mothers who went into labor, Mother who has had use
of antibiotics in the last 7 days, WHO Clinical HIV stage III and IV and mothers who
do not consent to the study.



Age minimum: 18 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Post Operative Infections
Intervention(s)
Drug: Multiple dose antibiotic
Drug: Single dose antibiotic
Primary Outcome(s)
Post operative wound infections [Time Frame: 14 days]
Secondary Outcome(s)
clinical endometritis [Time Frame: 14 days]
febrile morbidity [Time Frame: 14 days]
Secondary ID(s)
2013/HD07/658U
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history